Penumbra, Inc. (PEN)
| Market Cap | 9.71B |
| Revenue (ttm) | 995.06M |
| Net Income (ttm) | 40.61M |
| Shares Out | 38.60M |
| EPS (ttm) | 1.04 |
| PE Ratio | 241.87 |
| Forward PE | 92.73 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 140,267 |
| Open | 255.03 |
| Previous Close | 255.47 |
| Day's Range | 250.47 - 257.41 |
| 52-Week Range | 180.93 - 348.67 |
| Beta | 0.62 |
| Analysts | Strong Buy |
| Price Target | 310.10 (+23.28%) |
| Earnings Date | Feb 22, 2024 |
About PEN
Penumbra, Inc., together with its subsidiairies, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and oth... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for PEN stock is "Strong Buy." The 12-month stock price forecast is $310.1, which is an increase of 23.28% from the latest price.
News
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference
ALAMEDA, Calif. , Dec. 18, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P.
First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism
First-of-its-kind randomized controlled trial comparing computer assisted vacuum thrombectomy (CAVT) using Penumbra's Lightning Flash™ with anticoagulation versus anticoagulation alone Penumbra's Indi...
Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
ALAMEDA, Calif. , Nov. 14, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 35th Annual Healthcare Conference on Tu...
Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging Veterans
ALAMEDA, Calif., Nov. 10, 2023 /PRNewswire/ -- Everyday, memories of the people who served in World War II, Vietnam, and the Korean War are disappearing from living history.
Penumbra, Inc. Reports Third Quarter 2023 Financial Results
ALAMEDA, Calif. , Nov. 2, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter ended Sep...
NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES
Latest STRIKE-PE data show that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain; it also improved clinical and...
Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023
ALAMEDA, Calif. , Oct. 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2023 after market close...
Penumbra, Inc. to Present at Upcoming Investor Conferences
ALAMEDA, Calif. , Aug. 23, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times...
Top 5 Health Care Stocks That Could Blast Off In August
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Penumbra, Inc. Reports Second Quarter 2023 Financial Results
ALAMEDA, Calif. , Aug. 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarter ended Ju...
Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference
ALAMEDA, Calif. , July 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 43rd Annual Growth Conference on We...
Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023
ALAMEDA, Calif. , July 5, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2023 after market clos...
Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
Lightning Bolt™ 7 is the most advanced arterial thrombectomy system on the market Latest technology combines modulated aspiration with superior catheter design to maximize blood clot removal in a sing...
Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock Conference
ALAMEDA, Calif. , May 24, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at William Blair's 43rd Annual Growth Stock Conference on Wed...
Penumbra, Inc. Reports First Quarter 2023 Financial Results
ALAMEDA, Calif. , May 2, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended Marc...
Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023
ALAMEDA, Calif. , April 4, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2023 after market clos...
Penumbra and Veterans Health Administration to Expand Access to Rehabilitative Care using Virtual Reality
Penumbra enters a three-year collaboration with VHA Office of Healthcare Innovation and Learning to test, co-develop and scale virtual reality solutions Collaboration to develop and implement therapy ...
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
Les Funtleyder, portfolio manager for E Squared Capital Management, joins 'The Exchange' to discuss big cap pharma's Q1 performance, the dollar weakness contributing to biotech gains, and investment o...
Are These Medical Device Makers Getting Ready To Rally?
Large-cap medical device maker Stryker Corp. (NYSE: SYK) is consolidating along its 50-day moving average, a bullish sign as the stock takes a breather after a run-up that began last year.
Penumbra, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
ALAMEDA, Calif. , Feb. 23, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and ful...
Penumbra, Inc. to Present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Conference
ALAMEDA, Calif. , Feb. 16, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at Citi's 2023 Healthcare Services, Medtech, Tools & HCIT Co...
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 23, 2023
ALAMEDA, Calif. , Jan. 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2022 af...
PENUMBRA LAUNCHES LATEST INNOVATION IN MECHANICAL THROMBECTOMY: LIGHTNING FLASH™
Lightning Flash™ is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus Next generation technology combines superior catheter design with the latest...
Penumbra, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
ALAMEDA, Calif. , Dec. 19, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 41st Annual J.P.